关注
Mario Colucci
Mario Colucci
在 uniba.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cultured human endothelial cells generate tissue factor in response to endotoxin.
M Colucci, G Balconi, R Lorenzet, A Pietra, D Locati, MB Donati, ...
The Journal of clinical investigation 71 (6), 1893-1896, 1983
6471983
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
M Colucci, JA Paramo, D Collen
The Journal of clinical investigation 75 (3), 818-824, 1985
5521985
Sepsis, thrombosis and organ dysfunction
N Semeraro, CT Ammollo, F Semeraro, M Colucci
Thrombosis research 129 (3), 290-295, 2012
3972012
Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
JA Paramo, M Colucci, D Collen, F Van de Werf
British Medical Journal (Clinical research ed.) 291 (6495), 573, 1985
3821985
The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
O Amengual, T Atsumi, MA Khamashta, GRV Hughes
Thrombosis and haemostasis 79 (02), 276-281, 1998
3481998
Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation
LO Mosnier, PAK von dem Borne, JCM Meijers, BN Bouma
Thrombosis and haemostasis 80 (11), 829-835, 1998
2971998
Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients
Y Vanrenterghem, T Lerut, L Roels, J Gruwez, P Michielsen, ...
The Lancet 325 (8436), 999-1002, 1985
2591985
Tissue factor in health and disease
N Semeraro, M Colucci
Thrombosis and haemostasis 78 (07), 759-764, 1997
2491997
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis
M Colucci, BM Binetti, MG Branca, C Clerici, A Morelli, N Semeraro, ...
Hepatology 38 (1), 230-237, 2003
2172003
Sepsis-associated disseminated intravascular coagulation and thromboembolic disease
N Semeraro, CT Ammollo, F Semeraro, M Colucci
Mediterranean journal of hematology and infectious diseases 2 (3), 2010
1982010
Tissue factor expression and metastatic potential of colorectal cancer
C Shigemori, H Wada, K Matsumoto, H Shiku, S Nakamura, H Suzuki
Thrombosis and haemostasis 80 (12), 894-898, 1998
1841998
Coagulopathy of acute sepsis
N Semeraro, CT Ammollo, F Semeraro, M Colucci
Seminars in thrombosis and hemostasis 41 (06), 650-658, 2015
1512015
Evidence that cells from experimental tumours can activate coagulation factor X
L Curatolo, M Colucci, AL Cambini, A Poggi, L Morasca, MB Donati, ...
British Journal of Cancer 40 (2), 228-233, 1979
1501979
Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy
A Mele, F Tancredi, L Romano, A Giuseppone, M Colucci, A Sangiuolo, ...
The Journal of infectious diseases 184 (7), 905-908, 2001
1402001
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition …
P Gresele, S Momi, M Berrettini, GG Nenci, HP Schwarz, N Semeraro, ...
The Journal of clinical investigation 101 (3), 667-676, 1998
1341998
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues
R Lorenzet, G Peri, D Locati, P Allavena, M Colucci, N Semeraro, ...
1291983
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells
L Gesualdo, E Ranieri, R Monno, MR Rossiello, M Colucci, N Semeraro, ...
Kidney international 56 (2), 461-470, 1999
1281999
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor
CT Ammollo, F Semeraro, F Incampo, N Semeraro, M Colucci
Journal of Thrombosis and Haemostasis 8 (4), 790-798, 2010
1202010
Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation
MW Mosesson
Thrombosis and haemostasis 89 (01), 9-12, 2003
1112003
Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols)
C Mauz-Körholz, R Junker, U Göbel, U Nowak-Göttl
Thrombosis and haemostasis 83 (06), 840-843, 2000
1102000
系统目前无法执行此操作,请稍后再试。
文章 1–20